George Soros’ Top 5 Stock Picks

Page 5 of 5

1. Horizon Therapeutics Public Limited Company (NASDAQ:HZNP)

Soros Fund Management’s Holdings: $359,267,161
Percentage of Soros Fund Management’s Portfolio: 5.53%

Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) is a biotech company that develops and sells medicines for rare, autoimmune, and severe inflammatory diseases. They have a portfolio of 12 medicines for rare diseases, gout, ophthalmology, and inflammation.

George Soros loaded up on Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) in the first quarter of 2023, increasing his hold on the company by 16%. Soros Fund Management owns 3.29 million shares of the company, worth $359.27 million.

In its Q1 2023 investor letter, Aristotle Atlantic Partners, LLC provided the following statement regarding Horizon Therapeutics Public Limited Company (NASDAQ:HZNP):

“We sold Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) after Amgen announced their intention to acquire Horizon for $116.50 per share. The deal is expected to close in mid-year 2023.”

Follow Horizon Therapeutics Public Ltd Co (NASDAQ:HZNP)

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily newsletter to get  the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out our articles on Billionaire Ken Fisher’s Top 10 Stock Picks and 11 Best Data Center Stocks to Buy Now.

Page 5 of 5